PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'MSMA member since 2020, Assistant Professors, Division of Pulmonary, Critical Care, and Environmental Medicine, Department of Medicine, University of Missouri - Columbia School of Medicine, Columbia, Missouri.\', \'Internal Medicine Resident Physicians, Department of Medicine, University of Missouri - Columbia School of Medicine, Columbia, Missouri.\', \'Medicine-Pediatrics Resident Physician, MedStar Georgetown University Hospital Washington, DC.\', \'MSMA member since 2003, is a Hospitalist at North Kansas City Hospital and Liberty Hospital, Kansas City, Missouri.\', \'Assistant Professors, Division of Pulmonary, Critical Care, and Environmental Medicine, Department of Medicine, University of Missouri - Columbia School of Medicine, Columbia, Missouri.\']
?:citedBy
  • -1
?:creator
?:hasPublicationType
?:journal
  • Missouri medicine
is ?:pmid of
?:pmid
?:pmid
  • 32848272
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.148
?:rankingScore_hIndex
  • 17
is ?:relation_isRelatedTo_publication of
?:title
  • Increased Incidence, Morbidity, and Mortality in Human Coronavirus NL63 Associated with ACE Inhibitor Therapy and Implication in SARS-CoV-2 (COVID-19).
?:type

Metadata

Anon_0  
expand all